Related references
Note: Only part of the references are listed.Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae
Luckshman Ganeshanandan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Immune dysregulation increases the incidence of delayed-type drug hypersensitivity reactions
Dean J. Naisbitt et al.
ALLERGY (2020)
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study
Michael R. Sperling et al.
EPILEPSIA (2020)
Role of Mitochondria in the Redox Signaling Network and Its Outcomes in High Impact Inflammatory Syndromes
Natalia D. Magnani et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Cell Membrane Transporters Facilitate the Accumulation of Hepatocellular Flucloxacillin Protein Adducts: Implication in Flucloxacillin-Induced Liver Injury
James C. Waddington et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2020)
Exploratory Study of Autoantibody Profiling in Drug-Induced Liver Injury with an Autoimmune Phenotype
Craig Lammert et al.
HEPATOLOGY COMMUNICATIONS (2020)
Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved Drugs
Robert N. Schuck et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Emerging Cellular Therapies: T Cells and Beyond
Stephen Todryk et al.
CELLS (2019)
Exosomal Transport of Hepatocyte-Derived Drug-Modified Proteins to the Immune System
Monday O. Ogese et al.
HEPATOLOGY (2019)
Hepatocyte-Derived Exosomes Promote Liver Immune Tolerance: Possible Implications for Idiosyncratic Drug-Induced Liver Injury
Natalie S. Holman et al.
TOXICOLOGICAL SCIENCES (2019)
Rotenone Increases Isoniazid Toxicity but Does Not Cause Significant Liver Injury: Implications for the Hypothesis that Inhibition of the Mitochondrial Electron Transport Chain Is a Common Mechanism of Idiosyncratic Drug-Induced Liver Injury
Tiffany Cho et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2019)
Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
Audrey Simonaggio et al.
JAMA ONCOLOGY (2019)
Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis
Sabine Weber et al.
LIVER INTERNATIONAL (2019)
Drug-induced liver injury
Raul J. Andrade et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation
Joel Zindel et al.
Annual Review of Pathology-Mechanisms of Disease (2019)
A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury
Elizabeth T. Cirulli et al.
GASTROENTEROLOGY (2019)
Liver damage related to immune checkpoint inhibitors
Naoshi Nishida et al.
HEPATOLOGY INTERNATIONAL (2019)
Involvement of CCL2/CCR2 macrophage recruitment in amodiaquine-induced liver injury
Alastair Mak et al.
Journal of Immunotoxicology (2019)
Immunotherapy-related hepatitis: real-world experience from a tertiary centre
Vincent Cheung et al.
FRONTLINE GASTROENTEROLOGY (2019)
Current insights in the complexities underlying drug-induced cholestasis
Neel Deferm et al.
CRITICAL REVIEWS IN TOXICOLOGY (2019)
Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy
Shannan R. Tujios et al.
LIVER INTERNATIONAL (2018)
Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI
Rosa Chan et al.
TOXICOLOGICAL SCIENCES (2018)
Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results
Anthony Papp et al.
BURNS (2018)
The Effects of Immune Modulators on Amodiaquine-Induced Liver Injury
Alastair Mak et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2018)
Interaction of Nevirapine with the Peptide Binding Groove of HLA-DRB1*01:01 and Its Effect on the Conformation of HLA-Peptide Complex
Makoto Hirasawa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
Eleonora De Martin et al.
JOURNAL OF HEPATOLOGY (2018)
Use of an animal model to test whether non-alcoholic fatty liver disease increases the risk of idiosyncratic drug-induced liver injury
Alastair Mak et al.
JOURNAL OF IMMUNOTOXICOLOGY (2018)
End of the road for daclizumab in multiple sclerosis
[Anonymous]
LANCET (2018)
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
Loris Riccardo Lopetuso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Liver Toxicity with Cancer Checkpoint Inhibitor Therapy
Brian A. Nadeau et al.
SEMINARS IN LIVER DISEASE (2018)
Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy
Johanna Hynynen et al.
EPILEPSIA (2018)
Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury?
Ann K. Daly
PHARMACEUTICAL RESEARCH (2017)
Characterization of Isoniazid-Specific T-Cell Clones in Patients with anti-Tuberculosis Drug-Related Liver and Skin Injury
Toru Usui et al.
TOXICOLOGICAL SCIENCES (2017)
Severe Delayed Drug Reactions Role of Genetics and Viral Infections
Rebecca Pavlos et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2017)
Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B*35:02 as a risk factor
Thomas Jacob Urban et al.
JOURNAL OF HEPATOLOGY (2017)
Effects of immunization and checkpoint inhibition on amodiaquine-induced liver injury
Alastair Mak et al.
JOURNAL OF IMMUNOTOXICOLOGY (2017)
HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity
Hanna Lundgren et al.
PLOS ONE (2017)
Exosomes, DAMPs and miRNA: Features of Stress Physiology and Immune Homeostasis
Monika Fleshner et al.
TRENDS IN IMMUNOLOGY (2017)
Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer
Zachary J. Brown et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury
Ynto S. de Boer et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Supernatant from Hepatocyte Cultures with Drugs That Cause Idiosyncratic Liver Injury Activates Macrophage Inflammasomes
Ryuji Kato et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2017)
Mitochondria are the powerhouses of immunity
Evanna L. Mills et al.
NATURE IMMUNOLOGY (2017)
Hepatotoxicity Associated with the Use of Anti-TNF-α Agents
Joshua B. French et al.
DRUG SAFETY (2016)
RUCAM in Drug and Herb Induced Liver Injury: The Update
Gaby Danan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review
Jonathan G. Stine et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Oxidative stress markers, secondary bile acids and sulfated bile acids classify the clinical liver injury type: Promising diagnostic biomarkers for cholestasis
Noriko Masubuchi et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
Krista Dubin et al.
NATURE COMMUNICATIONS (2016)
Ipilimumab-associated Hepatitis Clinicopathologic Characterization in a Series of 11 Cases
Melanie Johncilla et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Drug-induced liver injury: an overview over the most critical compounds
Einar S. Bjornsson
ARCHIVES OF TOXICOLOGY (2015)
The Combination of Anti-CTLA-4 and PD1-/- Mice Unmasks the Potential of Isoniazid and Nevirapine To Cause Liver Injury
Alastair Mak et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
The Role of CD8 T Cells in Amodiaquine-Induced Liver Injury in PD1-/- Mice Cotreated with Anti-CTLA-4
Alastair Mak et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis
D. M. Foureau et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
How to Diagnose and Exclude Drug-Induced Liver Injury
Paul B. Watkins
DIGESTIVE DISEASES (2015)
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
Naga Chalasani et al.
GASTROENTEROLOGY (2015)
Treatment of PD-1-/- Mice With Amodiaquine and Anti-CTLA4 Leads to Liver Injury Similar to Idiosyncratic Liver Injury in Patients
Imir G. Metushi et al.
HEPATOLOGY (2015)
Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment
Mala Chakraborty et al.
HEPATOLOGY (2015)
HLA-allelotype associations with nevirapine-induced hypersensitivity reactions and hepatotoxicity: a systematic review of the literature and meta-analysis
Elena M. Cornejo Castro et al.
PHARMACOGENETICS AND GENOMICS (2015)
Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset
Imir G. Metushi et al.
JOURNAL OF IMMUNOTOXICOLOGY (2015)
Hepatitis B virus reactivation with a rituximab-containing regimen
Yutaka Tsutsumi et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
No Contribution of the ABCB11 p.444A Polymorphism in Japanese Patients with Drug-Induced Cholestasis
Tatehiro Kagawa et al.
DRUG METABOLISM AND DISPOSITION (2015)
Involvement of Myeloperoxidase and NADPH Oxidase in the Covalent Binding of Amodiaquine and Clozapine to Neutrophils: Implications for Drug-Induced Agranulocytosis
Alexandra R. Lobach et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Mild Isoniazid-Induced Liver Injury in Humans Is Associated with an Increase in Th17 Cells and T Cells Producing IL-10
Imir G. Metushi et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Clozapine Promotes the Proliferation of Granulocyte Progenitors in the Bone Marrow Leading to Increased Granulopoiesis and Neutrophilia in Rats
Alexandra R. Lobach et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Steroid Use in Acute Liver Failure
Jamuna Karkhanis et al.
HEPATOLOGY (2014)
Human Drug-Induced Liver Injury Severity Is Highly Associated With Dual Inhibition of Liver Mitochondrial Function and Bile Salt Export Pump
Michael D. Aleo et al.
HEPATOLOGY (2014)
Detection of Anti-Isoniazid and Anti-Cytochrome P450 Antibodies in Patients With Isoniazid-Induced Liver Failure
Imir G. Metushi et al.
HEPATOLOGY (2014)
Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management
Maja Mockenhaupt
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2014)
A new paradigm: innate immune sensing of viruses via the unfolded protein response
Judith A. Smith
FRONTIERS IN MICROBIOLOGY (2014)
Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature
Ravish Parekh et al.
CASE REPORTS IN GASTROINTESTINAL MEDICINE (2014)
12-OH-Nevirapine Sulfate, Formed in the Skin, Is Responsible for Nevirapine-Induced Skin Rash
Amy M. Sharma et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2013)
Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases
Marwan Ghabril et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Isoniazid-induced cell death is precipitated by underlying mitochondrial complex I dysfunction in mouse hepatocytes
Kang Kwang Lee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells
Sebastien Antherieu et al.
HEPATOLOGY (2013)
Human Leukocyte Antigen (HLA)-B☆57:01-Restricted Activation of Drug-Specific T Cells Provides the Immunological Basis for Flucloxacillin-Induced Liver Injury
Manal M. Monshi et al.
HEPATOLOGY (2013)
At the Bedside: CTLA-4-and PD-1-blocking antibodies in cancer immunotherapy
Margaret K. Callahan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Hepatotoxicity with Combination of Vemurafenib and Ipilimumab
Antoni Ribas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pharmacogenomics of adverse drug reactions
Ann K. Daly
GENOME MEDICINE (2013)
Idiosyncratic Adverse Drug Reactions: Current Concepts
Jack Uetrecht et al.
PHARMACOLOGICAL REVIEWS (2013)
Abacavir induces loading of novel self-peptides into HLA-B*57:01: an autoimmune model for HLA-associated drug hypersensitivity
Michael A. Norcross et al.
AIDS (2012)
Bioactivation of Nevirapine to a Reactive Quinone Methide: Implications for Liver Injury
Amy M. Sharma et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Direct Oxidation and Covalent Binding of Isoniazid to Rodent Liver and Human Hepatic Microsomes: Humans Are More Like Mice than Rats
Imir G. Metushi et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Genetic association studies in drug-induced liver injury
Ann K. Daly et al.
DRUG METABOLISM REVIEWS (2012)
Successful Translation of Pharmacogenetics into the Clinic
Elizabeth Phillips et al.
Molecular Diagnosis & Therapy (2012)
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
David A. Ostrov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury
Eric S. Orman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome
Tai-Ming Ko et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Involvement of T Helper 17 Cells in D-Penicillamine-Induced Autoimmune Disease in Brown Norway Rats
Xu Zhu et al.
TOXICOLOGICAL SCIENCES (2011)
A Case of Rituximab-Induced Hepatitis
Christopher Joseph Del Prete et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
Polymerase γ Gene POLG Determines the Risk of Sodium Valproate-Induced Liver Toxicity
Joanna D. Stewart et al.
HEPATOLOGY (2010)
Immune tolerance: What is unique about the liver
Gisa Tiegs et al.
JOURNAL OF AUTOIMMUNITY (2010)
Interference with Bile Salt Export Pump Function Is a Susceptibility Factor for Human Liver Injury in Drug Development
Ryan E. Morgan et al.
TOXICOLOGICAL SCIENCES (2010)
Metabolic activation of the phenothiazine antipsychotics chlorpromazine and thioridazine to electrophilic iminoquinone species in human liver microsomes and recombinant P450s
Bo Wen et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Bioactivation of Minocycline to Reactive Intermediates by Myeloperoxidase, Horseradish Peroxidase, and Hepatic Microsomes: Implications for Minocycline-Induced Lupus and Hepatitis
Baskar Mannargudi et al.
DRUG METABOLISM AND DISPOSITION (2009)
A Study of the Specificity of Lymphocytes in Nevirapine-Induced Skin Rash
Xin Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Ann K. Daly et al.
NATURE GENETICS (2009)
Sensitivity of Liver Injury in Heterozygous Sod2 Knockout Mice Treated with Troglitazone or Acetaminophen
Kazunori Fujimoto et al.
TOXICOLOGIC PATHOLOGY (2009)
Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose
R. Scott Obach et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis
A. Kindmark et al.
PHARMACOGENOMICS JOURNAL (2008)
The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury
E. Bjornsson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities
Michie M. K. Ong et al.
TOXICOLOGICAL SCIENCES (2007)
Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury
Carmen Lang et al.
PHARMACOGENETICS AND GENOMICS (2007)
Current concepts in the pathophysiology and treatment of aplastic anemia
Neal S. Young et al.
BLOOD (2006)
Brief communication: Severe hepatotoxicity of telithromycin: Three case reports and literature review
KD Clay et al.
ANNALS OF INTERNAL MEDICINE (2006)
Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump
R Kubitz et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Monitoring and management of antituberculosis drug induced hepatotoxicity
S Agal et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
A comparison of the covalent binding of clozapine, procainamide, and vesnarinone to human neutrophils in vitro and rat tissues in vitro and in vivo
I Gardner et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis?
L Palenzuela et al.
CLINICAL INFECTIOUS DISEASES (2005)
Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNFα
C Eriksson et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Hepatic findings in long-term clinical trials of ximelagatran
WM Lee et al.
DRUG SAFETY (2005)
Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity
GP Aithal et al.
HEPATOLOGY (2004)
Tolerance induced by low dose D-penicillamine in the brown Norway rat model of drug-induced autoimmunity is immune-mediated
MJ Masson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development
DC Evans et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Characterization of a potential animal model of an idiosyncratic drug reaction: Nevirapine-induced skin rash in the rat
JM Shenton et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2003)
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
G Ostapowicz et al.
ANNALS OF INTERNAL MEDICINE (2002)
The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymes
JS Walsh et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2002)
Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment
SK Sharma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept
Werner J. Pichler
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2002)
No one is naive: The significance of heterologous T-cell immunity
RM Welsh et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate
C Funk et al.
TOXICOLOGY (2001)
The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions
K Fattinger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Identification of a reactive metabolite of terbinafine: Insights into terbinafine-induced hepatotoxicity
SL Iverson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Share Paper
